A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

@article{Schuirmann2005ACO,
  title={A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability},
  author={D. Schuirmann},
  journal={Journal of Pharmacokinetics and Biopharmaceutics},
  year={2005},
  volume={15},
  pages={657-680}
}
  • D. Schuirmann
  • Published 2005
  • Mathematics, Medicine
  • Journal of Pharmacokinetics and Biopharmaceutics
The statistical test of the hypothesis of no difference between the average bioavailabilities of two drug formulations, usually supplemented by an assessment of what the power of the statistical test would have been if the true averages had been inequivalent, continues to be used in the statistical analysis of bioavailability/bioequivalence studies. In the present article, this Power Approach (which in practice usually consists of testing the hypothesis of no difference at level 0.05 and… Expand
1,516 Citations

Paper Mentions

Interventional Clinical Trial
Patients are often counseled to keep a surgical wound dry for 2 to 3 days. The rationale is likely to decrease the risk of infection and bleeding. However, this has never been formally… Expand
ConditionsSurgical Wound Infection
InterventionBehavioral
Interventional Clinical Trial
Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir and Ledipasvir from… Expand
ConditionsHealthy
InterventionDrug
Interventional Clinical Trial
Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier… Expand
ConditionsHealthy
InterventionDrug
Interventional Clinical Trial
An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals… Expand
ConditionsHealthy
InterventionDrug
Exact calculation of power and sample size in bioequivalence studies using two one-sided tests.
  • 8
  • Highly Influenced
  • PDF
An approximate approach to sample size determination in bioequivalence testing with multiple pharmacokinetic responses.
  • 6
Testing bioequivalence for multiple formulations with power and sample size calculations.
  • 10
AN INTERACTIVE SAS/A~ SYSTEM FOR ASSESSING BIOEQUIVALENCE
  • PDF
Statistical approaches to establishing bioequivalence
  • 131
Sample Size Determination for a Three-Arm Equivalence Trial of Normally Distributed Responses
  • 6
A Novel Approach to Testing for Average Bioequivalence Based on Modeling the Within-Period Dependence Structure
  • Highly Influenced
...
1
2
3
4
5
...

References

SHOWING 1-8 OF 8 REFERENCES
A new procedure for testing equivalence in comparative bioavailability and other clinical trials
  • 194
  • Highly Influential
A new statistical procedure for testing equivalence in two-group comparative bioavailability trials
  • 96
Comparison of different methods for decision-making in bioequivalence assessment.
  • 133
An exact confidence interval from untransformed data for the ratio of two formulation means
  • Charles Locke
  • Mathematics, Medicine
  • Journal of Pharmacokinetics and Biopharmaceutics
  • 2005
  • 54
On testing for bioequivalence.
  • 42
Bioequivalence testingneed to rethink
  • Biometrics
  • 1981
The design and analysis of comparative blood-level trials
  • Lea and Febiger, Philadelphia,
  • 1973